Prognostic Significance of p53 and Bcl-2 in Colorectal Cancer
Author Information
Author(s): RAEM Tollenaar, JHJM van Krieken, H-J van Slooten, DJ Bruinvels, KMJ Nelemans, LJ van den Broek, J Hermans, JH van Dierendonck
Primary Institution: Leiden University Medical Center
Hypothesis
The study evaluates the prognostic significance of p53 and Bcl-2 proteins in colorectal cancer.
Conclusion
The study found that immunohistochemical detection of p53 and Bcl-2 does not provide relevant prognostic information for colorectal cancer patients.
Supporting Evidence
- 35% of carcinomas showed no nuclear staining for p53.
- 51% of tumors were completely negative for Bcl-2.
- An association was found between nuclear p53 accumulation and mucinous tumors.
Takeaway
The study looked at two proteins in colorectal cancer to see if they could help predict how patients would do, but they didn't find any useful information.
Methodology
The study analyzed tissue sections from 238 colorectal carcinomas using immunohistochemistry to assess p53 and Bcl-2 expression.
Limitations
The study did not find significant correlations between p53 or Bcl-2 expression and clinicopathological parameters or patient survival.
Participant Demographics
Patients who underwent curative resection for colorectal adenocarcinoma without adjuvant chemotherapy.
Statistical Information
P-Value
0.01
Statistical Significance
p=0.01
Want to read the original?
Access the complete publication on the publisher's website